josti5 schreef:
'er zullen vast nog vrij innige banden bestaan.'
Yep, da's overduidelijk te zien aan de deal van vandaag!
[/quote]
Bv, een Galapagos J&J deal:
www.cnbc.com/id/21448392[quote=cnbc]
Galapagos Signs Major Arthritis Deal with J&J
24 Oct 2007
Belgian biotechnology company Galapagos said on Wednesday it had signed a deal potentially worth up to one billion euros with Johnson & Johnson unit Janssen Pharmaceutica.
Galapagos, which specializes in bone and joint diseases, will enter into a global alliance with Janssen on rheumatoid arthritis research.
Shares in the company shot up at the opening and were 12 percent higher at 7.6 euros.
Galapagos will receive 15 million euros ($21.3 million) in upfront cash payments plus a first 2 million euro alliance milestone payment. It will also receive yearly option fees and is eligible for discovery, development, regulatory and sales milestones and royalties on worldwide sales.
Highlights include up to 430 million euros in development and regulatory milestone payments should more than one product be launched and up to 346 million euros of sales milestones as well as double-digit royalties.
"Between five and eight years, a substantial part of these milestone payments should come into the company," Chief Executive Officer Onno van de Stolpe told a conference call.